International trade judge suggests a 10-year ban on a Botox rival

International trade judge suggests a 10-year ban on a Botox rival

More reads

• AbbVie may face fewer wrinkles after judge suggests a 10-year ban on a Botox rival. (STAT Plus)
• A swift big pharma endorsement for Kiadis. (Evaluate Vantage)
• Drug prices steadily rise amid pandemic, data shows. (Politico)
• RA Capital's SPAC prices upsized $118 million IPO. (Renaissance Capital)